The "Affordable Medicines" Reimbursement Program in Ukraine: Framework Assessment and Impact Evaluation.

Objectives: In 2017, the government of Ukraine introduced the new Affordable Medicines Program (AMP) for outpatient prescription medicines reimbursement. Despite the evident program implementation benefits, it is highly important to examine the AMP framework to reveal its current tendencies, strengths, and shortcomings that might be useful to support further development and improvement of reimbursement models. This study aimed to evaluate how the pricing strategies applied by the AMP framework might affect the potential to provide patients with affordable medicines.

[Use of transesophageal left atrial cardiac pacing for assessment of cordarone effectiveness in patients with atrioventricular tachycardia].

Aim: To assess by means of transesophageal left atrial pacing the effectiveness of cordarone treatment for arrhythmias caused by re-entry mechanism.

Materials And Methods: Effectiveness of cordarone treatment was estimated in 25 patients with atrioventricular nodal tachycardia (AVNT) and in 33 patients with WPW syndrome and reciprocal atrioventricular tachycardia (RAVT) with frequent paroxysms of tachycardia 1-5 times per week. Transesophageal left atrial pacing (TELAP) was performed before antiarrhythmic treatment and on cordarone treatment day 14-18.

Combined transesophageal left atrial pacing and antiarrhythmic therapy in the treatment of atrial flutter.

In order to terminate atrial flutter (AF) overdrive transesophageal left atrial pacing (TELAP) was performed in 760 patients with paroxysmal AF. There were 315 women and 415 men (mean age 59 years). In 260 patients, TELAP was used in an outpatient setting.

[Comparative analysis of the significance of transesophageal stimulation of the left atrium and bicycle ergometry in the detection of residual myocardial ischemia during the early period of myocardial infarct].

The study was undertaken to compare transesophageal left atrial pacing (TLAP) and bicycle ergometry (BE) in the detection of residual myocardial ischemia (RMI) in 187 patients with myocardial infarction in the early periods of the disease (on days 20 to 26). The intensity of TLAP and BE was increased up to the threshold and submaximal levels according to the conventional criteria. Among the patients, RMI was detected in 71% with TLAP and in 55% with BE (p less than greater than 0.